The epigenetic studies in NLRP3 modulation give excellent evidence and optimism for future research and therapy options for CNS disorders via modification of the NLRP3 inflammasome pathway (Poli et al. 2020). This evidence concerns the gene NLRP3 and central nervous system disorder.